These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1428464)

  • 1. The vasoconstrictor assay in bioequivalence testing: practical concerns and recent developments.
    Stoughton RB
    Int J Dermatol; 1992 Oct; 31 Suppl 1():26-8. PubMed ID: 1428464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials of topical corticosteroids in psoriasis: correlations with the vasoconstrictor assay.
    Cornell RC
    Int J Dermatol; 1992 Oct; 31 Suppl 1():38-40. PubMed ID: 1428467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence of topical corticosteroids: a regulatory perspective.
    Williams RL
    Int J Dermatol; 1992 Oct; 31 Suppl 1():2-5. PubMed ID: 1428462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vehicle design for a new topical steroid, fluocinonide.
    Ostrenga J; Haleblian J; Poulsen B; Ferrell B; Mueller N; Shastri S
    J Invest Dermatol; 1971 May; 56(5):392-9. PubMed ID: 5556528
    [No Abstract]   [Full Text] [Related]  

  • 5. Status of topical therapy.
    Stoughton RB
    Clin Pharmacol Ther; 1974 Nov; 16(5 Part 2):869-72. PubMed ID: 4425251
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical corticosteroids: clinical pharmacology and therapeutic use.
    Miller JA; Munro DD
    Drugs; 1980 Feb; 19(2):119-34. PubMed ID: 7363838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches to assess topical corticosteroid bioequivalence: pharmacokinetic evaluation.
    Pershing LK
    Int J Dermatol; 1992 Oct; 31 Suppl 1():14-20. PubMed ID: 1428461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An attempt to evaluate the relative clinical potencies of various diluted and undiluted proprietary corticosteroid preparations.
    Gibson JR; Kirsch J; Darley CR; Burke CA
    Br J Dermatol; 1983 Jul; 109 Suppl 25():114-6. PubMed ID: 6860578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human test models for bioequivalence of topical corticosteroids: a review.
    Olsen EA
    Int J Dermatol; 1992 Oct; 31 Suppl 1():9-13. PubMed ID: 1428469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of the relationship between vasoconstrictor assay findings, clinical efficacy and skin thinning effects of a variety of undiluted and diluted corticosteroid preparations.
    Gibson JR; Kirsch JM; Darley CR; Harvey SG; Burke CA; Hanson ME
    Br J Dermatol; 1984 Jul; 111 Suppl 27():204-12. PubMed ID: 6378245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are generic formulations equivalent to trade name topical glucocorticoids?
    Stoughton RB
    Arch Dermatol; 1987 Oct; 123(10):1312-4. PubMed ID: 3662563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency assessment of topical corticoids in the vasoconstrictor assay and on tuberculin-induced inflammation.
    Schalla W; Schorning S
    Skin Pharmacol; 1991; 4(3):191-204. PubMed ID: 1768431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paired comparison vasoconstrictor assays. A comparison of methods for the determination of relative vasoconstrictor potency of topically applied corticosteroids.
    Poulsen BJ; Burdick K; Bessler S
    Arch Dermatol; 1974 Mar; 109(3):367-71. PubMed ID: 4814938
    [No Abstract]   [Full Text] [Related]  

  • 14. Various vagaries of vasoconstriction.
    Burdick KH
    Arch Dermatol; 1974 Aug; 110(2):238-42. PubMed ID: 4855376
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantification of corticosteroid-induced skin vasoconstriction: visual ranking, chromameter measurement or digital imaging analysis.
    Smith EW; Haigh JM; Surber C
    Dermatology; 2002; 205(1):3-10. PubMed ID: 12145427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers.
    Kecskés A; Jahn P; Wendt H; Kleine-Kuhlmann R; Lange L
    Arzneimittelforschung; 1993 Feb; 43(2):144-7. PubMed ID: 8457237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. Method, reliability, errors (author's transl)].
    Zaun H; Altmeyer P
    Arch Dermatol Forsch; 1973; 247(4):379-86. PubMed ID: 4767633
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical clobetasol propionate in the treatment of psoriasis: a review of newer formulations.
    Feldman SR; Yentzer BA
    Am J Clin Dermatol; 2009; 10(6):397-406. PubMed ID: 19824740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use of topical cortisteroids.
    Sneddon IB
    Drugs; 1976; 11(3):193-9. PubMed ID: 776579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind controlled comparison of generic and trade-name topical steroids using the vasoconstriction assay.
    Olsen EA
    Arch Dermatol; 1991 Feb; 127(2):197-201. PubMed ID: 1990984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.